166 related articles for article (PubMed ID: 129288)
21. [Neutralizing antibodies to Coxsackie virus group B 1986-1988].
Kuljić-Kapulica N; Zivanović-Marinković V; Krstić L; Nozić M; Budisin A
Vojnosanit Pregl; 1990; 47(4):294-6. PubMed ID: 2173272
[TBL] [Abstract][Full Text] [Related]
22. Coxsackie B viruses and heart muscle disease in Nigerian adults.
Falase AO; Fabiyi A; Odegbo-Olukoya OO
Trop Geogr Med; 1979 Jun; 31(2):237-43. PubMed ID: 228451
[TBL] [Abstract][Full Text] [Related]
23. Antibody responses of rhesus (Macaca mulatta) monkeys experimentally infected with coxsackieviruses of group B and group A, type 9. II. Heterotypic antibody responses to echoviruses, polioviruses and reovirus type 1.
Schmidt NJ; Dennis J; Lennette EH
J Immunol; 1967 May; 98(5):1060-6. PubMed ID: 4290493
[No Abstract] [Full Text] [Related]
24. [Determination of antibody levels against coxsackie B virus type 2 and type 3 in sera from blood donors using the microneutralization test].
Kocabeyoğlu O; Toker A; Akça Y; Emekdaş G; Burgu I
Mikrobiyol Bul; 1989 Jul; 23(3):220-4. PubMed ID: 2562136
[TBL] [Abstract][Full Text] [Related]
25. Immunity status against coxsackie viruses B in 25 patients with acute myocarditis.
Băicuş A; Persu A; Popa MI; Băicuş C
Roum Arch Microbiol Immunol; 2006; 65(3-4):109-12. PubMed ID: 18389726
[TBL] [Abstract][Full Text] [Related]
26. Coxsackie B viruses and the post-viral syndrome.
Martin RW
J R Coll Gen Pract; 1987 May; 37(298):223. PubMed ID: 2826780
[No Abstract] [Full Text] [Related]
27. [The accumulation of antihemagglutinating and virus neutralizing antibodies to ECHO viruses].
Savchenko BI; Gubenko TL
Mikrobiol Zh; 1972; 34(1):52-4. PubMed ID: 5077259
[No Abstract] [Full Text] [Related]
28. The role of coxsackie B viruses in heart disease in New Zealand.
Lau RC; Hermon YE
N Z Med J; 1979 Nov; 90(647):375-7. PubMed ID: 230431
[TBL] [Abstract][Full Text] [Related]
29. [Persistence of latex agglutination inhibition antibodies in rabbits following application of poliomyelitis-, Coxsackie-, Echo- and encephalomyocarditis viruses. Brief report].
Schmidt WA; Brade H; Klein M
Arch Virol; 1975; 47(3):291-4. PubMed ID: 164163
[No Abstract] [Full Text] [Related]
30. Relationship between poliovirus and echovirus 6 antigens. II. Antibody patterns in sera from patients with poliovirus infections.
Forsgren M
Arch Gesamte Virusforsch; 1972; 39(1):121-31. PubMed ID: 4344138
[No Abstract] [Full Text] [Related]
31. Tests for coxsackie B virus-specific IgM.
Pattison JR
J Hyg (Lond); 1983 Jun; 90(3):327-32. PubMed ID: 6306096
[No Abstract] [Full Text] [Related]
32. Humoral immune response of the duck to duck hepatitis virus: virus-neutralizing vs. virus-precipitating antibodies.
Toth TE; Norcross NL
Avian Dis; 1981; 25(1):17-28. PubMed ID: 6268049
[TBL] [Abstract][Full Text] [Related]
33. [Coxsackie viruses and diabetes mellitus].
Cihula J; Horácek J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1978; 21(5):499-506. PubMed ID: 228385
[No Abstract] [Full Text] [Related]
34. Coxsackie virus infection in association with heart affection in man.
Petrovicová A; Cervenka J; Egnerová A
J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):251-7. PubMed ID: 2824602
[TBL] [Abstract][Full Text] [Related]
35. Antibodies against coxsackie B2 virus in infants and children in Delhi.
Santhanam S; Choudhury DS
J Commun Dis; 1984 Dec; 16(4):304-6. PubMed ID: 6100184
[No Abstract] [Full Text] [Related]
36. Detection of IgM antibodies against coxsackie B viruses by a western blot technique.
del Rosario Zuñiga M; Reichardt J; Braun W; Weber B; Doerr HW
Acta Virol; 1993 Feb; 37(1):1-10. PubMed ID: 8105643
[TBL] [Abstract][Full Text] [Related]
37. Type 1 diabetes and Coxsackie virus infection.
Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
[TBL] [Abstract][Full Text] [Related]
38. [The role of enterovirus in the pathogenesis of Insulin-dependent diabetes mellitus].
Hyöty H
Duodecim; 1996; 112(4):243-5. PubMed ID: 10590635
[No Abstract] [Full Text] [Related]
39. [A contribution to the methodology of preparation of antigens of Coxsackie B viruses for immunodiffusion (author's transl)].
Cupková E
Cesk Epidemiol Mikrobiol Imunol; 1973 Nov; 22(6):324-7. PubMed ID: 4271762
[No Abstract] [Full Text] [Related]
40. [Inactivated combined Coxsackie A-9 and B-1 as well as Echo-6 vaccine. I. Basic studies].
Biernacki M; Jabloński L
Med Dosw Mikrobiol; 1974; 26(4):339-45. PubMed ID: 4444375
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
